Free Trial

Traws Pharma (TRAW) SEC Filings & 10K Form

Traws Pharma logo
$1.26 +0.06 (+5.00%)
Closing price 05/22/2025 04:00 PM Eastern
Extended Trading
$1.28 +0.02 (+1.59%)
As of 05/22/2025 07:47 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Traws Pharma SEC Filings

DateFilerForm TypeView
05/19/2025
7:00 AM
Traws Pharma, Inc. (Filer)
Traws Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/15/2025
4:26 PM
Ikarian Capital, LLC (Filed by)
Traws Pharma, Inc. (Subject)
Traws Pharma (Subject)
Form SCHEDULE 13G/A
05/15/2025
6:00 AM
Traws Pharma, Inc. (Filer)
Traws Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/12/2025
8:02 AM
Adage Capital Management, L.P. (Filed by)
Traws Pharma, Inc. (Subject)
Traws Pharma (Subject)
Form SCHEDULE 13G
04/08/2025
7:32 PM
Savchuk Nikolay (Reporting)
TPAV, LLC (Reporting)
Traws Pharma, Inc. (Issuer)
Traws Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/07/2025
4:00 PM
Traws Pharma, Inc. (Filer)
Traws Pharma (Filer)
Form 424B5
04/07/2025
4:03 PM
Traws Pharma, Inc. (Filer)
Traws Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/31/2025
3:35 PM
Traws Pharma, Inc. (Filer)
Traws Pharma (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/31/2025
8:21 AM
Traws Pharma, Inc. (Filer)
Traws Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/28/2025
3:30 PM
Traws Pharma, Inc. (Filer)
Traws Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/25/2025
6:30 AM
Traws Pharma, Inc. (Filer)
Traws Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/24/2025
6:00 AM
Traws Pharma, Inc. (Filer)
Traws Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/21/2025
6:01 AM
Traws Pharma, Inc. (Filer)
Traws Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/10/2025
3:45 PM
Traws Pharma, Inc. (Filer)
Traws Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/10/2025
3:53 PM
Traws Pharma, Inc. (Filer)
Traws Pharma (Filer)
Form 424B5
03/03/2025
6:00 AM
Traws Pharma, Inc. (Filer)
Traws Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/28/2025
6:01 AM
Traws Pharma, Inc. (Filer)
Traws Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/19/2025
5:23 PM
CAUTREELS WERNER (Reporting)
Traws Pharma, Inc. (Issuer)
Traws Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2025
12:18 PM
Ikarian Capital, LLC (Filed by)
Traws Pharma, Inc. (Subject)
Traws Pharma (Subject)
Form SCHEDULE 13G
02/13/2025
12:07 PM
Ayrton Capital LLC (Filed by)
Traws Pharma, Inc. (Subject)
Traws Pharma (Subject)
Form SCHEDULE 13G
02/07/2025
7:16 PM
Brennan Nora (Reporting)
Traws Pharma, Inc. (Issuer)
Traws Pharma (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
02/07/2025
3:30 PM
Traws Pharma, Inc. (Filer)
Traws Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/29/2025
5:42 PM
ORBIMED ADVISORS LLC (Filed by)
Traws Pharma, Inc. (Subject)
Traws Pharma (Subject)
Form SCHEDULE 13D/A
01/27/2025
6:00 PM
Savchuk Nikolay (Reporting)
Traws Pharma, Inc. (Issuer)
Traws Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/27/2025
6:01 PM
TPAV, LLC (Reporting)
Traws Pharma, Inc. (Issuer)
Traws Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/27/2025
6:02 PM
CAUTREELS WERNER (Reporting)
Traws Pharma, Inc. (Issuer)
Traws Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/27/2025
6:03 PM
ORBIMED ADVISORS LLC (Reporting)
OrbiMed Capital GP VIII LLC (Reporting)
Traws Pharma, Inc. (Issuer)
Traws Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/23/2025
6:00 AM
Traws Pharma, Inc. (Filer)
Traws Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/22/2025
11:15 PM
Traws Pharma, Inc. (Filer)
Traws Pharma (Filer)
Form EFFECT
01/15/2025
5:33 AM
Traws Pharma, Inc. (Filer)
Traws Pharma (Filer)
Form S-3
Registration statement under Securities Act of 1933  
01/08/2025
8:28 PM
PERCEPTIVE ADVISORS LLC (Filed by)
Traws Pharma, Inc. (Subject)
Traws Pharma (Subject)
Form SCHEDULE 13G
12/31/2024
4:23 PM
Traws Pharma, Inc. (Filer)
Traws Pharma (Filer)
Form 424B4
12/31/2024
4:23 PM
Traws Pharma, Inc. (Filer)
Traws Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/20/2024
4:00 PM
Traws Pharma, Inc. (Filer)
Traws Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/22/2024
4:00 PM
Traws Pharma, Inc. (Filer)
Traws Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/01/2024
4:15 PM
Traws Pharma, Inc. (Filer)
Traws Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/23/2024
4:00 PM
Traws Pharma, Inc. (Filer)
Traws Pharma (Filer)
Form ARS
10/11/2024
7:46 AM
Traws Pharma, Inc. (Filer)
Traws Pharma (Filer)
Form DEF 14A
09/27/2024
4:10 PM
Traws Pharma, Inc. (Filer)
Traws Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/23/2024
5:44 PM
ORBIMED ADVISORS LLC (Filed by)
Traws Pharma, Inc. (Subject)
Traws Pharma (Subject)
Form SC 13D
09/23/2024
3:42 PM
ORBIMED ADVISORS LLC (Reporting)
OrbiMed Capital GP VIII LLC (Reporting)
Traws Pharma, Inc. (Issuer)
Traws Pharma (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
Gold Hits New Highs as Global Markets Spiral (Ad)

When Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. Now… as new tariffs take effect, gold is breaking records again. You've hopefully already seen this in action… but gold is surpassing $3,000 per ounce for the first time EVER.

Go Here to Learn What's Happening and How to Prepare >>
09/17/2024
4:06 PM
Traws Pharma, Inc. (Filer)
Traws Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/17/2024
4:11 PM
Greenwood Luba (Reporting)
Traws Pharma, Inc. (Issuer)
Traws Pharma (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
09/17/2024
4:12 PM
Greenwood Luba (Reporting)
Traws Pharma, Inc. (Issuer)
Traws Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/30/2024
5:02 AM
Traws Pharma, Inc. (Filer)
Traws Pharma (Filer)
Form 424B3
08/28/2024
11:15 PM
Traws Pharma, Inc. (Filer)
Traws Pharma (Filer)
Form EFFECT
08/23/2024
4:15 PM
Traws Pharma, Inc. (Filer)
Traws Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/15/2024
6:30 AM
Traws Pharma, Inc. (Filer)
Traws Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/15/2024
5:03 AM
Traws Pharma, Inc. (Filer)
Traws Pharma (Filer)
Form NT 10-Q
08/09/2024
5:00 AM
Traws Pharma, Inc. (Filer)
Traws Pharma (Filer)
Form DEF 14A
08/07/2024
2:46 PM
Savchuk Nikolay (Reporting)
Traws Pharma, Inc. (Issuer)
Traws Pharma (Issuer)
Form 4/A
08/07/2024
2:47 PM
Dukes Iain D. (Reporting)
Traws Pharma, Inc. (Issuer)
Traws Pharma (Issuer)
Form 4/A
07/30/2024
2:14 PM
Traws Pharma, Inc. (Filer)
Traws Pharma (Filer)
Form PRER14A
07/19/2024
3:01 PM
Traws Pharma, Inc. (Filer)
Traws Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/01/2024
3:49 PM
Traws Pharma, Inc. (Filer)
Traws Pharma (Filer)
Form S-3
Registration statement under Securities Act of 1933  
06/21/2024
4:21 PM
Traws Pharma, Inc. (Filer)
Traws Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/17/2024
4:20 PM
Traws Pharma, Inc. (Filer)
Traws Pharma (Filer)
Form 8-K/A
05/22/2024
4:25 PM
Traws Pharma, Inc. (Filer)
Traws Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:TRAW) was last updated on 5/23/2025 by MarketBeat.com Staff
From Our Partners